3-methoxytyramine has been researched along with Disease Exacerbation in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mount, HT | 1 |
| Martel, JC | 1 |
| Fluit, P | 1 |
| Wu, Y | 1 |
| Gallo-Hendrikx, E | 1 |
| Cosi, C | 1 |
| Marien, MR | 1 |
1 other study available for 3-methoxytyramine and Disease Exacerbation
| Article | Year |
|---|---|
Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Ataxia Telangiectas | 2004 |